{"url":"https://lda.senate.gov/api/v1/filings/da8da14c-dff7-48da-8bfb-8cf50a7e9cf2/","filing_uuid":"da8da14c-dff7-48da-8bfb-8cf50a7e9cf2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/da8da14c-dff7-48da-8bfb-8cf50a7e9cf2/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Charles Cooper","dt_posted":"2024-07-22T11:16:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"221 10th Street, SE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":401107154,"url":"https://lda.senate.gov/api/v1/registrants/401107154/","house_registrant_id":55854,"name":"BRUMIDI GROUP","description":null,"address_1":"221 10th Street, SE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHARLES COOPER","contact_telephone":"+1 202-930-0184","dt_updated":"2026-07-14T10:04:45.461885-04:00"},"client":{"id":54803,"url":"https://lda.senate.gov/api/v1/clients/54803/","client_id":54803,"name":"SUPERGOOP!","general_description":"Retail","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues generally related to sunscreen use (no specific legislation introduced or pending in 2024 Q2)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140878,"prefix":null,"prefix_display":null,"first_name":"MADELINE","nickname":null,"middle_name":null,"last_name":"WADE","suffix":null,"suffix_display":null},"covered_position":"Special Projects Director, Rep. Greg Walden (7/2012-2/2014)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}